Publications
Recent studies from Yale’s broad, multidisciplinary community investigating psychedelic science.
Journal Articles
- Psychedelic Medicine: Creating an Introductory Course for Mental Health Professionals and Trainees.Prueitt WL, Sloshower J. Acad Psychiatry. 2023 Feb; 2022 May 26. PMID: 35616783.
- Psychedelics.Kelmendi B, Kaye AP, Pittenger C, Kwan AC. Curr Biol. 2022 Jan 24. PMID: 35077687.
- Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. Neuron. 2021 Aug 18; 2021 Jul 5. PMID: 34228959.
- Research abuses against people of colour and other vulnerable groups in early psychedelic research.Strauss D, de la Salle S, Sloshower J, Williams MT. J Med Ethics. 2021 Jul 12; 2021 Jul 12. PMID: 34253622.
- A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.Savalia NK, Shao LX, Kwan AC. Trends Neurosci. 2021 Apr; 2020 Dec 21. PMID: 33358035.
- Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC. Neurotherapeutics. 2021 Jan; 2020 Nov 12. PMID: 33184743.
- Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A. Elife. 2018 Oct 25; 2018 Oct 25. PMID: 30355445.
- Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.Schindler EAD, Wallace RM, Sloshower JA, D'Souza DC. Front Pharmacol. 2018; 2018 Mar 1. PMID: 29545753.
- The role of psychedelics in palliative care reconsidered: A case for psilocybin.Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH. J Psychopharmacol. 2016 Dec. PMID: 27909173.
- Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Schindler EA, Gottschalk CH, Weil MJ, Shapiro RE, Wright DA, Sewell RA. J Psychoactive Drugs. 2015 Nov-Dec; 2015 Nov 23. PMID: 26595349.
- Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC. Biol Psychiatry. 2012 Nov 15; 2012 Jul 18. PMID: 22817868.